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Abstract Upon uracil depletion, the transcriptional activator
Ppr1p stimulates expression of the Saccharomyces cerevisiae
URA3 gene only four-fold. We performed a split-ubiquitin screen
with Tup1p as bait, and we found that the global repressor Tup1p
interacts with the transcriptional activator Ppr1p both in vivo
and in vitro. The interaction is biologically significant, since the
deletion of the TUP1 gene as well as the removal of the Tup1p-
binding domain from Ppr1p results in an increased expression of
the URA3 gene. Our results suggest that Tup1p blocks Ppr1p
directly, and that Ppr1p is a weak activator of transcription
because of its interaction with Tup1p. Thus we were able to
demonstrate that the global repressor Tup1p can modulate
transcription by interacting with an activator. ß 2001 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Tup1p is a general repressor of RNA polymerase II tran-
scription that is directed to its target promoters by speci¢c
DNA-binding proteins such as K2p, Mig1p, or Rox1p [1].
Thus Tup1p is involved in the repression of the mating
type-speci¢c genes, the glucose-repressed genes, and the an-
aerobic genes, amongst others. Tup1p contains seven WD
repeats [2], and a direct protein interaction between the C-
terminal WD repeat and K2p has been demonstrated [3].
Tup1p binds to the N-terminal tails of the histones H3 and
H4 [4], and the deletion of these tails results in the derepres-
sion of some, but not all, Tup1p-repressed genes [5^7]. Ssn6p,
which is known to form a complex with Tup1p [8], interacts
with the histone deacetylases Rpd3p and Hos2p, and the triple
deletion of Rpd3p, Hos1p, and Hos2p leads to the derepres-
sion of the Tup1p-repressed genes MFA2 and SUC2 [9].
Therefore, Tup1p could function by forcing its target genes
into a chromatin structure unfavorable for transcription.
However, Tup1p also interacts with the holoenzyme compo-
nent Srb7p. Srb7p is an essential gene involved in both tran-
scriptional activation and repression [10], and the disruption
of the Tup1p^Srb7p interaction leads to the derepression of
Tup1p-repressed genes as well [11]. Taken together, these ob-
servations suggest that Tup1p can function by in£uencing
both the holoenzyme of transcription and the chromatin
structure of the target gene.
The Saccharomyces cerevisiae URA3 gene encodes oroti-
dine-5P-phosphate decarboxylase (Ura3p), an enzyme required
for uracil biosynthesis. The URA3 gene contains six posi-
tioned nucleosomes £anked by nuclease-sensitive regions at
the 5P and 3P ends [12]. The ura3-52 allele, which is commonly
used in laboratory strains, contains a Ty insertion in the cod-
ing region of the URA3 gene [13]. The transcriptional activa-
tor of the URA3 gene is Ppr1p. The N-terminal 123 amino
acids of Ppr1p contain a Zn2Cys6 binuclear cluster domain
responsible for binding speci¢cally to a single DNA-binding
site in the URA3 promoter [14]. The activation domain is
located within the C-terminal 134 amino acids [15]. Ppr1p
(904 aa) is homologous to Gal4p (881 aa), but whereas
Gal4 activates transcription more than 1000-fold from a single
site [16], Ppr1p activates only four-fold from its site in the
URA3 promoter [17].
The split-ubiquitin assay is an alternative yeast two-hybrid
assay whose readout is not based upon transcription but upon
proteolytic stability [18]. The split-ubiquitin assay is therefore
suited for the analysis of transcription factors [19,20]. A fu-
sion containing ubiquitin and Ura3p with an arginine in posi-
tion 1 (RUra3p) is cleaved by the ubiquitin-speci¢c proteases
(UBPs). The free RUra3p is degraded so rapidly by the en-
zymes of the N-end rule [21] that the cells are uracil-auxotro-
phic and resistant to the drug 5-£uoro-orotic acid (FOA; Fig.
1A, line 1). If only the C-terminal half of ubiquitin (Cub) is
used in a fusion, no cleavage is observed (Fig. 1A, line 2). The
RUra3p part of the fusion is enzymatically active, and cells
expressing the fusion are phenotypically uracil-prototrophic
and FOA-sensitive. If the N-terminal half of ubiquitin (Nub)
and Cub are fused to two interacting proteins X and Y respec-
tively, the local concentration of Nub and Cub is raised, and a
native-like ubiquitin is formed. The native-like ubiquitin is
recognized by the UBPs and cleaved. Subsequently, the free
RUra3p is rapidly degraded by the enzymes of the N-end rule
(Fig. 1A, line 3). The cells have thus become uracil-auxotro-
phic and FOA-resistant as a consequence of the protein inter-
action between X and Y inside the cell.
A library of genomic S. cerevisiae DNA fragments has been
fused to Nub and screened for proteins binding to the general
transcriptional repressor Tup1p in vivo [22]. Here we report
that the transcriptional activator Ppr1p binds the transcrip-
tional repressor Tup1p. The interaction between Tup1p and
Ppr1p was con¢rmed in vivo with the help of a Tup1-Cub-
RGFP reporter and in vitro with puri¢ed proteins. The inter-
action is biologically relevant, as both the deletion of the
TUP1 gene and the removal of the Tup1p-interacting domain
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from Ppr1p raised the level of the URA3 transcript. Our re-
sults suggest that Ppr1p is a weak activator of transcription
because Tup1p blocks its activation function.
2. Materials and methods
2.1. Strains and plasmids
The S. cerevisiae strains used are JD52 and JD53 [23]. For the
experiments presented in Fig. 4, the wild-type URA3 locus was recon-
structed by homologous recombination of a functional URA3 gene
into the URA3 locus carrying the ura3-52 Ty insertion. The recon-
struction was con¢rmed by Southern blotting. The TUP1 deletion
strains have been described [22]. The PPR1 deletion strain was gen-
erated by deleting the entire open reading frame (ORF) with a HIS3-
based knockout vector containing 500 bp from promoter and termi-
nator. Genomic DNA was isolated of all strains, and the deletions of
the respective genes were veri¢ed by PCR and Southern blotting. The
Escherichia coli strain used for protein puri¢cations was BL21(DE3)-
LysS (Stratagene). The single-copy Nub and Cub fusion vectors have
been described [22]. The GST-Ppr1p fusions were made by cloning the
ORFs into GEX-5X-1 (Pharmacia). H6hemagglutinin (HA)-Tup1p
was made by cloning a PCR fragment containing the TUP1 ORF,
six histidines and an HA tag into pET11a (Novagen).
2.2. The split-ubiquitin screen
The split-ubiquitin screen with Tup1p as bait has been described
[22]. One of the clones isolated contained a Sau3A fragment fusing
amino acid residues 97^208 of Ppr1p in frame to Nub.
2.3. In vitro binding assays
The GST fusion proteins were puri¢ed according the protocol of
the manufacturer (Pharmacia, Freiburg). The H6HA-Tup1 protein
was loaded onto a Ni-column (Pharmacia, Freiburg) and eluted
with stepwise increasing concentrations of imidazole. The peak frac-
tion appeared at 250 mM imidazole. Puri¢ed H6HA-Tup1p was in-
cubated together with the glutathione matrix containing the puri¢ed
GSTp (fusions) in phosphate-bu¡ered saline. After washing, the pel-
lets were resuspended in SDS sample bu¡er, loaded onto an 8% pro-
tein gel and analyzed by Western blot.
2.4. Western blots
Western blot analysis was performed according to [24]. Proteins
were detected with the anti-HA or anti-GST antibodies from Babco
(Berkeley, CA, USA). The secondary antibody (Bio-Rad, Hercules,
CA, USA) was visualized using the ECL1 Western Blotting-Detec-
tion kit (Amersham, Freiburg) following the manufacturer’s protocol.
2.5. Northern blots
Northern blots were performed as described [22].
3. Results
We have performed a split-ubiquitin screen with Tup1-Cub-
RUra3p as bait [22]. One of the clones isolated by its ability
to confer FOA resistance to an S. cerevisiae strain expressing
Tup1-Cub-RUra3p contained Nub fused in frame to residues
97^208 of Ppr1p (Fig. 1B, compare lines 1 and 2). We fused
Nub to full-length Ppr1p and found that full-length Ppr1p also
interacted with Tup1p (line 4). Deleting residues 124^208 of
Ppr1p eliminated the interaction (line 3), even though Nub-
Ppr1(1^123+209^904)p was expressed at levels comparable
to Nub-Ppr1p (Fig. 2A). We had used a Ura3p fusion as
reporter, and we had isolated Ppr1p, the activator of the
URA3 gene. Tup1-Cub-RUra3p was not expressed from the
URA3 promoter but from the CUP1 promoter. However, to
exclude that Ppr1p in£uenced the growth on the FOA plates
by a mechanism not based on the interaction between Ppr1p
and Tup1p, we con¢rmed the interaction with the help of a
green £uorescent protein (GFP)-based reporter. We found
that cells expressing Tup1-Cub-RGFP displayed green nuclear
£uorescence in the presence of Nub (Fig. 2B, left). Coexpres-
sion with Nub-Ppr1p led to the disappearance of the £uores-
cence, thereby re£ecting the interaction between Nub-Ppr1p
and Tup1-Cub-RGFP in the nucleus of the cell, the cleavage
of the Tup1-Cub-RGFP fusion by the UBPs, and the subse-
quent degradation of the RGFP moiety by the enzymes of the
N-end rule (Fig. 2B, middle). Again, deleting the Tup1p-in-
teracting domain from Ppr1p eliminated the interaction and
cells coexpressing Nub-Ppr1(1^123+209^904)p and Tup1-Cub-
RGFP showed strong nuclear green £uorescence (Fig. 2B,
right). The in vivo interaction between Ppr1p and Tup1p
was therefore con¢rmed by an assay not based upon Ura3p.
The split-ubiquitin assay detects close proximity of two
proteins inside the cell, but not necessarily a direct protein
contact. In order to ¢nd out if Ppr1p and Tup1p interacted
directly, we puri¢ed both proteins from E. coli. Tup1p was
Fig. 1. A split-ubiquitin screen revealed that Tup1p interacts with
Ppr1p in vivo. A: The split-ubiquitin system. A fusion protein con-
taining ubiquitin fused to Ura3p with an arginine as ¢rst amino
acid (RUra3p) is cleaved by the UBPs. The free RUra3p is rapidly
degraded by the enzymes of the N-end rule (line 1). If only Cub is
fused between a protein Y and RUra3p, no cleavage is observed.
Cells expressing this fusion are uracil-prototrophic and FOA-sensi-
tive (line 2). A protein X is fused to the N-terminal half of ubiqui-
tin. If X interacts with Y, a ubiquitin-like molecule is formed and
the fusion is cleaved by the UBPs. The free RUra3p is rapidly de-
graded by the enzymes of the N-end rule, resulting in uracil auxo-
trophy and FOA resistance (line 3). B: Tup1p interacted with Ppr1p
in vivo. Ten-fold serial dilutions of cells coexpressing the depicted
fusions were grown on plates lacking tryptophan and leucine (WL)
and on plates containing additionally FOA (FWL). Interaction was
revealed by the growth on the FWL plate.
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expressed as a fusion to six histidines and an HA tag, and
Ppr1p and Ppr1(1^123+209^904)p were expressed as GSTp
fusions. H6HA-Tup1p was puri¢ed via a Ni-column, and
GSTp, GST-Ppr1p, and GST-Ppr1(1^123+209^904)p were
bound to glutathione beads (Fig. 3A). Fig. 3B shows that
GST-Ppr1p, but not GST-Ppr1(1^123+209^904)p or GSTp
alone, was able to bind and retain H6HA-Tup1p on the ma-
trix. Since both interacting proteins were puri¢ed from a het-
erologous system, a direct interaction between Ppr1p and
Tup1p can be deduced. A degradation product of H6HA-
Tup1p consisting of approximately the N-terminal 300 resi-
dues was retained as well, suggesting that Ppr1p interacts with
the N-terminal half of Tup1p. Our ¢nding that the deletion of
the Tup1p-interacting domain from Ppr1p eliminated the in-
teraction both in vivo and in vitro showed that the interaction
observed in vitro was speci¢c and that it truly re£ected what
occurred in vivo.
Fig. 4A shows that the deletion of TUP1 from the chromo-
some of S. cerevisiae increased transcription of the URA3
gene. Consistent with previous reports [17], we found that
the depletion of uracil from the medium upregulated the
URA3 mRNA four-fold only (Fig. 4A, compare lanes 1 and
3). However, deleting TUP1 from this strain resulted in a 14-
fold increase in the expression of the URA3 gene in medium
containing uracil (compare lanes 3 and 4 or lanes 5 and 6) and
a seven-fold increase in medium lacking uracil (compare lanes
1 and 2). We deleted PPR1 from the chromosome and com-
plemented the deletion by expressing Nub-Ppr1p or Nub-
Ppr1(1^123+209^904)p. Fig. 4B shows that the Ppr1p deriva-
tive lacking the Tup1p-interacting domain activated transcrip-
tion three times stronger than the one containing the domain.
Thus we conclude that the transcriptional activator Ppr1p was
weakened by its interaction with Tup1p.
The Nub-Ppr1p derivatives were expressed from the strong
ADH1 promoter. Also, the constructs did not contain the
Fig. 2. Nub-Ppr1p, but not a derivative lacking the interaction do-
main, interacted with Tup1-Cub-RGFP in the nucleus of the cell.
A: Nub-Ppr1p (109 kDa, lane 1) and Nub-Ppr1(1^123+209^904)p
(100 kDa, lane 2) were expressed at comparable levels. Yeast cells
were suspended in loading bu¡er and proteins were separated on an
8% SDS gel. After blotting onto nitrocellulose, the Ppr1p derivatives
were detected by an HA tag present in the fusions. B: A GFP-
based reporter for the split-ubiquitin system con¢rmed the interac-
tion between Ppr1p and Tup1p. Cells expressing the depicted fu-
sions were analyzed under a Leitz £uorescence microscope. Phase
contrast (top line), £uorescence (middle line), and merged pictures
(bottom line) are shown.
Fig. 3. GST-Ppr1p, but neither GSTp nor GST-Ppr1(1^123+209^
904)p, interacted with H6HA-Tup1p in vitro. A: Puri¢cation of
GST-Ppr1p (129 kDa, lane 1) and GST-Ppr1(1^123+209^904)p (120
kDa, lane 2) from E. coli. The proteins were puri¢ed with a gluta-
thione matrix and an aliquot was analyzed by Western blotting with
the help of an anti-GSTp antibody (Babco). B: In vitro interaction
assay. Puri¢ed H6HA-Tup1p (81 kDa, lane 1) was incubated with
equal amounts of GSTp (lane 2), GST-Ppr1(1^123+209^904)p (lane
3), and GST-Ppr1p (lane 4) bound to the glutathione matrix. The
matrix was washed, eluted with SDS loading bu¡er and proteins
were separated on an SDS gel. After blotting onto nitrocellulose,
bound H6HA-Tup1p was detected with the help of an anti-HA anti-
body (Babco). A degradation product consisting of approximately
the N-terminal 300 amino acids of H6HA-Tup1p is indicated.
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degradation signal located in the 5P untranslated region of the
PPR1 mRNA. Apparently, the overexpression of Nub-Ppr1p
resulted in approximately three times more URA3 mRNA as
compared to wild-type Ppr1p expressed from its own pro-
moter (compare Fig. 4A, lane 1 with Fig. 4B, lane 1).
4. Discussion
We have shown that Tup1p represses transcription of the
URA3 gene. Our experiments suggest that Ppr1p is a weak
activator of transcription because of its interaction with
Tup1p. The experiments further suggest that the global
repressor Tup1p is recruited to the URA3 promoter by the
transcriptional activator Ppr1p, and that Tup1p blocks tran-
scriptional activation by direct interference. A genome-wide
expression pro¢le of a TUP1 deletion has been published
[25], but a signi¢cant increase in transcription of the URA3
gene had not been observed. The most likely explanation for
this discrepancy is that the pro¢le was made with an S. cere-
visiae strain carrying a Ty insertion in the URA3 gene and
that the insertion of this retrotransposon deregulates the
URA3 gene with respect to the repression by Tup1p.
An alternative explanation for the upregulation of the
URA3 gene upon deletion of TUP1 is that the deletions pos-
itively increase the transcription of the PPR1 gene and that
the observed e¡ects are therefore secondary. However, the
genome-wide expression pro¢le of the TUP1 deletion demon-
strated that this is not the case. We conclude that the ob-
served e¡ect is most likely to be a direct one.
The deletion of the TUP1 gene resulted in higher amounts
of URA3 transcript than the deletion of the Tup1p-interacting
domain in Ppr1p. There are two possible explanations for this
di¡erence. First, Ppr1(1^123+209^904)p might still have inter-
acted with Tup1p, but so weakly that we did not detect this
interaction with our methods. Second, Tup1p could have been
recruited by a second protein binding to the URA3 promoter.
One candidate for such a protein is Bas2p, another weak
activator with a putative binding site in the URA3 promoter
that has been shown to stimulate URA3 transcription in the
absence of adenine [26]. Hence this homeobox protein Bas2p
might have been able to recruit Tup1p to some extent, even if
Ppr1(1^123+209^904)p was not able to do so.
So far, only transcriptional repressors like K2p, Mig1p, or
Rox1p have been described to interact with Tup1p [1]. Our
¢ndings demonstrate that the global repressor Tup1p is capa-
ble of interacting with transcriptional activators as well, and
this increases the possibilities for Tup1p to modulate tran-
scription. But what are the advantages for the cell to combine
an activator with a repressor? We suggest two di¡erent rea-
sons for this. First, the interaction may be regulated in order
to give the cell the opportunity to produce a burst of Ura3p
when it is needed ^ for example during mRNA production in
the cell cycle. Changes in transcript level during the cell cycle
have been determined on a genome-wide scale [27], but since
the strains used carried the Ty insertion, the question of wild-
type URA3 mRNA levels changing during the cell cycle re-
mains open. Interestingly, the abundance of the TUP1 mRNA
was found to £uctuate during the cell cycle, peaking in G2
and M phases. Second, an ine⁄cient preform of the Ura3p
enzyme might have existed previously and high concentrations
of this preform were needed to produce su⁄cient amounts of
uracil. The preform improved during evolution and the cell
lowered the amount of Ura3p enzyme by attaching an inter-
action domain with a repressor to its activator, Ppr1p.
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